Found: 60
Select item for more details and to access through your institution.
Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1096, doi. 10.1007/s10637-019-00857-6
- By:
- Publication type:
- Article
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1117, doi. 10.1007/s10637-019-00856-7
- By:
- Publication type:
- Article
Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing.
- Published in:
- European Radiology, 2022, v. 32, n. 7, p. 4647, doi. 10.1007/s00330-022-08536-6
- By:
- Publication type:
- Article
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2017, v. 120, n. 5B, p. E30, doi. 10.1111/bju.13631
- By:
- Publication type:
- Article
Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) ( NCT01254279).
- Published in:
- BJU International, 2015, v. 116, n. 6, p. 880, doi. 10.1111/bju.13069
- By:
- Publication type:
- Article
Therapy monitoring of skeletal metastases with whole-body diffusion MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2014, v. 39, n. 5, p. 1049, doi. 10.1002/jmri.24548
- By:
- Publication type:
- Article
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 107, doi. 10.1007/s11060-018-2847-z
- By:
- Publication type:
- Article
PARP Inhibitors Mechanism of Action and Their Potential Role in the Prevention and Treatment of Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Management of Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221100022
- By:
- Publication type:
- Article
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Systematic study of tissue factor expression in solid tumors.
- Published in:
- Cancer Reports, 2023, v. 6, n. 2, p. 1, doi. 10.1002/cnr2.1699
- By:
- Publication type:
- Article
Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1838, doi. 10.2967/jnumed.116.179887
- By:
- Publication type:
- Article
Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 8, p. 747, doi. 10.1002/pros.24691
- By:
- Publication type:
- Article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e783, doi. 10.1093/oncolo/oyac172
- By:
- Publication type:
- Article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
- Published in:
- Oncologist, 2022, v. 27, n. 9, p. e783, doi. 10.1093/oncolo/oyac172
- By:
- Publication type:
- Article
Phase I Study of Nintedanib Incorporating Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 368, doi. 10.1634/theoncologist.2014-0250
- By:
- Publication type:
- Article
Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 10, p. 1413, doi. 10.1634/theoncologist.2011-0164
- By:
- Publication type:
- Article
Therapeutics targeting signal transduction for patients with colorectal carcinoma.
- Published in:
- British Medical Bulletin, 2002, v. 64, n. 1, p. 227, doi. 10.1093/bmb/64.1.227
- By:
- Publication type:
- Article
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067148
- By:
- Publication type:
- Article
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
- By:
- Publication type:
- Article
Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027419
- By:
- Publication type:
- Article
Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 17, p. 3185, doi. 10.1002/cncr.34366
- By:
- Publication type:
- Article
Molecular pathology and prostate cancer therapeutics: from biology to bedside.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 178, doi. 10.1002/path.4272
- By:
- Publication type:
- Article
Envisioning the future of early anticancer drug development.
- Published in:
- 2010
- By:
- Publication type:
- research
Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy ( STAMPEDE) trial.
- Published in:
- BJU International, 2013, v. 111, n. 5, p. 697, doi. 10.1111/bju.12087
- By:
- Publication type:
- Article
Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer.
- Published in:
- BJU International, 2005, v. 96, n. 9, p. 1241, doi. 10.1111/j.1464-410X.2005.05821.x
- By:
- Publication type:
- Article
Tumor clone dynamics in lethal prostate cancer.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 254, p. 1, doi. 10.1126/scitranslmed.3009448
- By:
- Publication type:
- Article
Future directions in the evaluation of c-MET-driven malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 1, p. S51, doi. 10.1177/1758834011423540
- By:
- Publication type:
- Article
c-MET: an exciting new target for anticancer therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2011, v. 3, n. 1, p. S3, doi. 10.1177/1758834011423402
- By:
- Publication type:
- Article
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 21, p. 3346, doi. 10.1002/cncr.28890
- By:
- Publication type:
- Article
The CT flare response of metastatic bone disease in prostate cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Bench to Bedside Development of [ 18 F]Fluoromethyl-(1,2- 2 H 4)choline ([ 18 F]D4-FCH).
- Published in:
- Molecules, 2023, v. 28, n. 24, p. 8018, doi. 10.3390/molecules28248018
- By:
- Publication type:
- Article
Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 31, doi. 10.3322/caac.20095
- By:
- Publication type:
- Article
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
- By:
- Publication type:
- Article
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
- By:
- Publication type:
- Article
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862995
- By:
- Publication type:
- Article
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 51, doi. 10.3390/cancers14010051
- By:
- Publication type:
- Article
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2334, doi. 10.3390/cancers13102334
- By:
- Publication type:
- Article
Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.
- Published in:
- Cancers, 2018, v. 10, n. 11, p. 416, doi. 10.3390/cancers10110416
- By:
- Publication type:
- Article
Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00644-w
- By:
- Publication type:
- Article
Novel Strategies to Test Biological Hypotheses in Early Drug Development for Advanced Prostate Cancer.
- Published in:
- Clinical Chemistry, 2013, v. 59, n. 1, p. 75, doi. 10.1373/clinchem.2012.185157
- By:
- Publication type:
- Article
Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 4, p. 765, doi. 10.1007/s00280-009-1083-9
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
- By:
- Publication type:
- Article
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0
- By:
- Publication type:
- Article
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476).
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 3, p. 422, doi. 10.1002/ijc.34018
- By:
- Publication type:
- Article